Fibrosis biomarker performance in NAFLD is markedly improved by BMI-specific cut-offs

Sami Qadri, Anni Poikola, Noora Ahlholm, Panu Luukkonen, Anne Juuti, Henna Sammalkorpi, Anne K. Penttilä, Johanna Arola, Kimmo Porthan, Serena Pelusi, Stergios Kechagias, Luca Valenti, Mattias Ekstedt, Hannele Yki-Järvinen

Research output: Contribution to journalMeeting Abstract

Original languageEnglish
JournalJournal of Hepatology
Volume75
Issue numberSuppl. 2
Pages (from-to)S260-S261
Number of pages2
ISSN0168-8278
DOIs
Publication statusPublished - 26 Jun 2021
MoE publication typeNot Eligible
EventThe International Liver Congress 2021 - Virtual
Duration: 23 Jun 202126 Jun 2021

Fields of Science

  • 3121 General medicine, internal medicine and other clinical medicine
  • obesity
  • biomarker
  • non-alcoholic fatty liver disease
  • fatty liver disease
  • fatty liver
  • NAFLD
  • NASH
  • cirrhosis
  • fibrosis
  • liver fibrosis
  • liver biopsy
  • non-alcoholic steatohepatitis
  • body mass index
  • BMI

Cite this